High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma
Author(s) -
Yan Tang,
Xuefeng Yang,
Kehai Feng,
Chang-Lu Hu,
Suyi Li
Publication year - 2021
Publication title -
journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.084
H-Index - 39
eISSN - 2219-679X
pISSN - 2078-6891
DOI - 10.21037/jgo-20-534
Subject(s) - cancer research , aldolase a , hepatocellular carcinoma , biology , proportional hazards model , glycolysis , oncology , medicine , enzyme , biochemistry , metabolism
Aldolase A (ALDOA), a key glycolytic enzyme, has been reported to play an important role in lung, pancreatic, and colorectal cancer. However, the role and mechanism of ALDOA in hepatocellular carcinoma (HCC) are still unclear. This study aimed to study the role and potential mechanism of ALDOA in HCC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom